These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 320485)

  • 1. Inhibition for immunosuppression.
    Lum CT; Sutherland DE; Najarian JS
    N Engl J Med; 1977 Apr; 296(14):819. PubMed ID: 320485
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenosine deaminase inhibition for immunosuppression.
    Chassin MM; Chirigos MA; Johns DG; Adamson RH
    N Engl J Med; 1977 May; 296(21):1232. PubMed ID: 854065
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
    Lum CT; Sutherland DE; Foker JE; Najarian JS
    Surg Forum; 1977; 28():320-2. PubMed ID: 364724
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the effects of infusion of enzyme inhibitors on mouse adenosine deaminase.
    Trotta PP; Ahland MP; Brown GF; Balis ME
    Mol Pharmacol; 1978 Jan; 14(1):199-209. PubMed ID: 625284
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3.
    Suling WJ; Rice LS; Shannon WM
    Cancer Treat Rep; 1978 Mar; 62(3):369-73. PubMed ID: 647695
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of methylation by adenosine in adenosine deaminase-inhibited, phytohemagglutinin-stimulated human lymphocytes.
    Johnston JM; Kredich NM
    J Immunol; 1979 Jul; 123(1):97-103. PubMed ID: 448160
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical basis of the increased activity of 9-beta-D-arabinofuranosyladenine in the presence of inhibitors of adenosine deaminase.
    Plunkett W; Alexander L; Chubb S; Loo TL
    Cancer Res; 1979 Sep; 39(9):3655-60. PubMed ID: 476690
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of adenosine deaminase and purine nucleoside phosphorylase and T-cell function in germfree mice and human peripheral blood.
    Wiedl SC; Bealmear PM; Epstein J
    Prog Clin Biol Res; 1985; 181():461-6. PubMed ID: 3927311
    [No Abstract]   [Full Text] [Related]  

  • 9. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
    Plunkett W; Cohen SS
    Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition.
    Bessodes M; Bastian G; Abushanab E; Panzica RP; Berman SF; Marcaccio EJ; Chen SF; Stoeckler JD; Parks RE
    Biochem Pharmacol; 1982 Mar; 31(5):879-82. PubMed ID: 7082355
    [No Abstract]   [Full Text] [Related]  

  • 11. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
    Earle MF; Glazer RI
    Mol Pharmacol; 1983 Jan; 23(1):165-70. PubMed ID: 6602939
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenosine deaminase inhibition and myocardial adenosine metabolism during ischemia.
    Achterberg PW; de Jong JW
    Adv Myocardiol; 1985; 6():465-72. PubMed ID: 3992044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lymphocyte-specific enzymes: a promising approach for selective immunosuppression.
    Ruers TJ; Buurman WA; van der Linden CJ; Kootstra G
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1287-9. PubMed ID: 3274319
    [No Abstract]   [Full Text] [Related]  

  • 14. EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes.
    Goday A; Simmonds HA; Webster DR; Morris GS
    Rev Esp Fisiol; 1985 Mar; 41(1):49-54. PubMed ID: 3923578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human T-cell rosette formation by the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
    Lum CT; Schmidtke JR; Sutherland DE; Najarian JS
    Clin Immunol Immunopathol; 1978 Jul; 10(3):258-61. PubMed ID: 307473
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of drug metabolism by a prodrug: 9-beta-D-arabinofuranosyladenine 5'-valerate as an inhibitor of adenosine deaminase.
    Lipper RA; Machkovech SM; Drach JC; Higuchi WI
    Mol Pharmacol; 1978 Mar; 14(2):366-9. PubMed ID: 642934
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of the bioactive enantiomer of erythro-3-(adenin-9-yl)-2-nonanol (EHNA), a semi-tight binding inhibitor of adenosine deaminase.
    Baker DC; Hanvey JC; Hawkins LD; Murphy J
    Biochem Pharmacol; 1981 May; 30(10):1159-61. PubMed ID: 7259798
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibition.
    Koller CA; Mitchell BS; Grever MR; Mejias E; Malspeis L; Metz EN
    Cancer Treat Rep; 1979; 63(11-12):1949-52. PubMed ID: 316725
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bovine heart adenosine deaminase activity by some pyrimidine analogues.
    Pechán I; Pechánová E; Krizko J; Starková B; Cihák A
    Neoplasma; 1983; 30(1):109-11. PubMed ID: 6835435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.